Search
Login
Register
Menu
BJMO
Home
News
CongressUpdate
Guidelines
Cancertrials
Specials
Patients
News
Oncopedia
All
All
BJMO articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ 5x 1 year subscription
“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart.
View cart
5x 1 year subscription
€
535.00
5x 1 year subscription quantity
Add to cart
Category:
General
Related products
Article: Highlights in gynaecological cancers
€
2.50
Add to cart
Article: Highlights in breast cancer
€
2.50
Add to cart
Article: Highlights in breast cancer
€
2.50
Add to cart
Article: Highlights in genitourinary cancers
€
2.50
Add to cart